PMC5247628_01
EUS image identifying the celiac axis with lack of significant vascular structures within the injection needle path.
CG-CGCR160160F001.jpg
PMC5247628_01_CG-CGCR160160F001.jpg
F1
Color Doppler guidance was used to confirm a lack of significant vascular structures within the injection needle path, and needle aspiration was performed prior to injection to exclude entry into a blood vessel (Figure 1).
EUS image showing successful injection of triamcinolone/bupivacaine in the area of the celiac plexus.
CG-CGCR160160F002.jpg
PMC5247628_01_CG-CGCR160160F002.jpg
F2
A total of 20 mL 0.25% bupivacaine and 2 mL 40 mg/mL triamcinolone (80 mg) were injected in the area of the celiac plexus using a 20-gauge needle during each procedure (Figure 2).